文献速递心脏核医学

疑似转甲状腺素蛋白心脏淀粉样变性患者中99mTc-焦磷酸盐摄取的预后价值

Prognostic value of 99mTc-pyrophosphate uptake in patients with suspected transthyretin cardiac amyloidosis.
PubMed 文献 · J Nucl Cardiol · 2025-08-05

该回顾性分析纳入301例因疑似转甲状腺素蛋白心脏淀粉样变性(ATTR-CA)接受99mTc-焦磷酸盐(PYP)显像的患者,按Perugini分级和心/对侧肺摄取比值(H/CL)评估心肌摄取。中位随访668天,PYP SPECT阳性者主要复合终点(心源性死亡及致死性室性心律失常)发生率显著高于阴性者(P=.018),且阳性为独立预测因子(校正HR 2.86,95%CI 1.10-7.41,P=.031)。

要点

  • 301例疑似ATTR-CA患者中90例SPECT心肌PYP摄取阳性。
  • 阳性者主要终点发生10/90(11%),阴性者8/211(4%),Kaplan-Meier分析P=.018。
  • PYP SPECT阳性为独立预测因子,校正HR 2.86(95%CI 1.10-7.41),P=.031。

核心结论

  • 显著心肌PYP摄取与疑似ATTR-CA患者不良心脏事件风险增加相关。

研究设计与样本

  • 回顾性分析连续纳入301例因疑似ATTR-CA接受PYP显像的患者。
  • 心肌PYP摄取采用Perugini分级(0-3级)视觉评估,并以心/对侧肺摄取比值(H/CL)量化。
  • 主要终点为心源性死亡与记录到的致死性室性心律失常(心室颤动[VF]及持续>30秒的持续性室性心动过速[VT])的复合终点。

主要发现

  • 301例中90例SPECT心肌PYP摄取阳性。
  • 中位随访668天(四分位距186-868天),36例死亡,中心源性死亡13例。
  • 记录到致死性室性心律失常6例(2例中止的心室颤动和4例持续性室性心动过速)。
  • 主要终点在PYP SPECT阴性者中发生8/211(4%),阳性者中发生10/90(11%)。
  • Kaplan-Meier分析显示PYP SPECT阳性者主要终点发生率显著高于阴性者(P=.018);两组全因死亡率无显著差异(P=.36)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aimed to evaluate the prognostic value of myocardial 99mTc-pyrophosphate (PYP) uptake in patients undergoing PYP imaging for suspected transthyretin cardiac amyloidosis (ATTR-CA). METHODS: A retrospective analysis of 301 consecutive patients who underwent PYP imaging for suspected ATTR-CA was performed. Myocardial PYP uptake was graded visually using the Perugini classification (grade 0-3) and quantified by the heart-to-contralateral lung uptake (H/CL) ratio. The primary outcome was combined cardiac death and documented fatal ventricular arrhythmias (ventricular fibrillation [VF] and sustained ventricular tachycardia [VT] lasting >30 seconds). RESULTS: Among the 301 patients, 90 had positive myocardial PYP uptake on SPECT. During a median follow-up of 668 days (interquartile range, 186-868 days), 36 patients died, including 13 cardiac deaths. Fatal ventricular arrhythmias were documented in 6 patients (2 aborted VF and 4 sustained VT). The primary outcome occurred in 8 of 211 (4%) patients with negative PYP SPECT and in 10 of 90 (11%) patients with positive PYP SPECT. Kaplan-Meier analyses showed a significantly higher incidence of the primary outcome in patients with positive PYP SPECT than in those without (P=.018). In contrast, all-cause mortality did not differ significantly between the two groups (P=.36). Multivariable Cox proportional hazards regression analyses showed that PYP SPECT positivity was an independent predictor of the primary outcome in patients with suspected ATTR-CA (adjusted hazard ratio: 2.86 [95% confidence interval: 1.10-7.41]; P =.031). CONCLUSIONS: Significant myocardial PYP uptake was associated with an increased risk of adverse cardiac events in patients with suspected ATTR-CA.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Ajima T, Aikawa T, Saitou T, et al. Prognostic value of 99mTc-pyrophosphate uptake in patients with suspected transthyretin cardiac amyloidosis. J Nucl Cardiol. 2025. PMID: 40759262. doi:10.1016/j.nuclcard.2025.102452

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。